Form Approved
O MB no. 0920-1317
Exp. Date: 03/31/2026
www.cdc.gov/nhsn
Page
*Required for submission
Facility Information |
|||
1 |
a. |
NHSN Org ID* |
|
|
b. |
Reporting Context* |
|
|
d. |
Weekending Date* |
|
Staffed Bed Capacity, Occupancy, and Prevalent Hospitalizations |
||||||||
|
||||||||
Important: Please ensure that the values reported for the Staffed Bed Capacity and Prevalent Hospitalization fields are not aggregated to weekly totals. The data should provide a single day snapshot of the overall, adult, and pediatric inpatient and ICU bed capacity and occupancy and COVID, influenza, and RSV prevalent hospitalizations specifically for Wednesday of the reporting week.
|
||||||||
Staffed Bed Capacity and Occupancy |
||||||||
Inpatient Beds |
ICU Beds |
|||||||
2a. All hospital inpatient beds * |
|
3a. All hospital inpatient occupancy* |
|
4a. All ICU beds* |
|
5a. All ICU bed occupancy* |
|
|
|
|
|
|
|
|
|
|
|
2b. All adult inpatient beds* |
|
3b. All adult inpatient occupancy* |
|
4b. Adult ICU beds* |
|
5b. Adult ICU bed occupancy* |
|
|
|
|
|
|
|
|
|
|
|
2c. All pediatric inpatient beds * |
|
3c. All pediatric inpatient occupancy * |
|
4c. Pediatric ICU beds* |
|
5c. Pediatric ICU bed occupancy* |
|
|
|
|
|
|
|
|
|
|
Prevalent Hospitalizations – COVID-19 |
||||
All hospitalizations |
ICU hospitalizations |
|||
6a. All hospitalized adult patients with laboratory- confirmed COVID-19* |
|
|
9a. Adult ICU patients with laboratory-confirmed COVID-19 * |
|
|
|
|
|
|
6b. All hospitalized pediatric patients with laboratory-confirmed COVID-19* |
|
|
9b. Pediatric ICU patients with laboratory-confirmed COVID-19* |
|
|
|
|
|
|
Assurance of Confidentiality: The voluntarily provided information obtained in this surveillance system that would permit identification of any individual or institution is collected with a guarantee that it will be held in strict confidence, will be used only for the purposes stated, and will not otherwise be disclosed or released without the consent of the individual, or the institution in accordance with Sections 304, 306 and 308(d) of the Public Health Service Act (42 USC 242b, 242k, and 242m(d)).
Public reporting burden of this collection of information is estimated to average 202 minutes, including the time for reviewing instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC, Reports Clearance Officer, 1600 Clifton Rd., MS H21-8, Atlanta, GA 30333, ATTN: PRA (0920-1317). CDC Rev (R11.6 – 10/21/2023)
Prevalent Hospitalizations – Influenza |
||||
All hospitalizations |
ICU hospitalizations |
|||
7a. All hospitalized adult patients with laboratory-confirmed influenza* |
|
|
10a. Adult ICU patients with laboratory-confirmed influenza* |
|
|
|
|
|
|
7b. All hospitalized pediatric patients with laboratory-confirmed influenza* |
|
|
10b. Pediatric ICU patients with laboratory-confirmed influenza* |
|
|
|
|
|
|
Prevalent Hospitalizations – RSV |
|||||
All hospitalizations |
ICU hospitalizations |
||||
8a. All hospitalized adult patients with laboratory-confirmed RSV* |
|
11a. Adult ICU patients with laboratory-confirmed RSV* |
|
|
|
|
|
|
|
|
|
8b. All hospitalized pediatric patients with laboratory-confirmed RSV* |
|
11b. Pediatric ICU patients with laboratory-confirmed RSV* |
|
|
|
|
|
|
|
|
Weekly Total New Hospital Admissions (Sunday-Saturday) |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Important: Data reported for the COVID-19, Influenza, and RSV new hospital admissions should reflect aggregate weekly totals for these fields. Please provide the weekly total new hospital admissions for the Sunday-Saturday reporting week.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Optional |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The below fields are optional for federal data collection. Hospitals are not required to report these data elements to the federal government.
Note: State, tribal, local, and territorial (STLT) partners may have reporting requirements related to or independent of the federal reporting requirements. Facilities are encouraged to work with relevant STLT partners to ensure complete reporting for all partners. |
PPE |
|
|||||
15a. On hand supply (DURATION in days) n95 respirators |
|
16a. Are you able to MAINTAIN at least a 3-day supply of these items (y/n/N/A)? N95 respirators |
|
|
|
|
|
|
|
|
|
||
15b. On hand supply (DURATION in days) surgical and procedure masks |
|
16b. Are you able to MAINTAIN at least a 3-day supply of these items (y/n/N/A)? Surgical and procedure masks |
|
|
|
|
|
|
|
|
|
||
15c. On hand supply (DURATION in days) eye protection including face shields and goggles |
|
16c. Are you able to MAINTAIN at least a 3-day supply of these items (y/n/N/A)? Eye protection including face shields and goggles |
|
|
||
|
|
|
|
|
||
15d. On hand supply (DURATION in days) single use gowns |
|
16d. Are you able to MAINTAIN at least a 3-day supply of these items (y/n/N/A)? Single use gowns |
|
|
||
|
|
|
|
|
||
15e. On hand supply (DURATION in days) exam gloves (sterile and non-sterile) |
|
16e. Are you able to MAINTAIN at least a 3-day supply of these items (y/n/N/A)? Exam gloves |
|
|
||
|
|
|
|
|
||
|
|
|
|
|
||
|
|
|
|
|
||
|
|
|
|
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Smith, Henrietta (CDC/DDID/NCEZID/DHQP) |
File Modified | 0000-00-00 |
File Created | 2024-10-31 |